Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F16%3A10312477" target="_blank" >RIV/00669806:_____/16:10312477 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11140/16:10312477
Result on the web
<a href="http://dx.doi.org/10.3324/haematol.2015.135681" target="_blank" >http://dx.doi.org/10.3324/haematol.2015.135681</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3324/haematol.2015.135681" target="_blank" >10.3324/haematol.2015.135681</a>

Result language
angličtina
Original language name
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status
Original language description
Treatment of acute myeloid leukemia (AML) is generally dictated by the patient's age and performance status and the biological, genetic, and molecular characteristics of the disease. Specific cytogenetic alterations divide AML classification into three risk-based categories: favorable, intermediate and unfavorable.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
<a href="/en/project/ED2.1.00%2F03.0076" target="_blank" >ED2.1.00/03.0076: Biomedical Centre of the Faculty of Medicine in Pilsen</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)